Differential pharmacological responses of catatonia-like signs in frontotemporal dementia (Q39835216)

15 September 2017

title

Differential pharmacological responses of catatonia-like signs in frontotemporal dementia (English)

1 reference

15 September 2017

0 references

frontotemporal dementia

1 reference

based on heuristic

inferred from title

author name string

Preetha Sharone Kuppuswamy

series ordinal

1 reference

15 September 2017

Edward C. Lauterbach

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20859826

17 July 2024

Lauren L. Greenway

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20859826

17 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20859826

17 July 2024

publication date

1 October 2010

1 reference

full work available at URL

15 September 2017

http://www.tandfonline.com/doi/pdf/10.1080/13554791003623326

1 reference

https://api.crossref.org/works/10.1080/13554791003623326

17 July 2024

1 reference

15 September 2017

1 reference

15 September 2017

1 reference

15 September 2017

page(s)

436-450

1 reference

Is the immobility of advanced dementia a form of lorazepam-responsive catatonia?

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Pramipexole--a new dopamine agonist for the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Repeated administration of antidepressants decreases field potentials in rat frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. A quantitative in situ hybridization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Catatonia. I. Rating scale and standardized examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Deformation-based morphometry reveals brain atrophy in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Goals in symptomatic pharmacologic management of frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

A 6-month, open-label study of memantine in patients with frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Clinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed frontal glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Frontotemporal dementia: recommendations for therapeutic studies, designs, and approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Do visuospatial and constructional disturbances differentiate frontal variant of frontotemporal dementia and Alzheimer's disease? an experimental study of a clinical belief

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Frontal Assessment Battery is a marker of dorsolateral and medial frontal functions: A SPECT study in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Somatic treatment of catatonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Correlation of ventricular asymmetry with metabolic asymmetry in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Baclofen-induced catatonia: modification by serotonergic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Galantamine in frontotemporal dementia and primary progressive aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Clinical significance of lobar atrophy in frontotemporal dementia: application of an MRI visual rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Frontotemporal dementia: a randomised, controlled trial with trazodone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Frontotemporal dementia with ubiquitinated neuronal inclusions and visuospatial impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Frontotemporal dementia: therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

An evidence-based review of the psychopathology of frontotemporal dementia: a report of the ANPA Committee on Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Benzodiazepines and catatonia: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Orbitofrontal cortical dysfunction in akinetic catatonia: a functional magnetic resonance imaging study during negative emotional stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Patterns of frontal lobe atrophy in frontotemporal dementia: a volumetric MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

The prevalence of frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Catatonia with frontal lobe atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Cognitive function and psychiatric symptoms in early- and late-onset frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Distinct behavioural profiles in frontotemporal dementia and semantic dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Memantine for behavioral disturbances in frontotemporal dementia: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Symptoms of frontotemporal dementia provide insights into orbitofrontal cortex function and social behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Frontotemporal dementias: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Rates of cerebral atrophy differ in different degenerative pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Rates of brain atrophy over time in autopsy-proven frontotemporal dementia and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

Diminution of basal ganglia dopaminergic function may play an important role in the generation of akinetic mutism in a patient with anterior cerebral arterial infarct

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554791003623326

21 January 2018

Bialek J.

1999

1 reference

https://api.crossref.org/works/10.1080/13554791003623326

17 July 2024

Pharmacological Reports

865

Bobula B.

2008

1 reference

https://api.crossref.org/works/10.1080/13554791003623326

The universal field hypothesis of catatonia and neuroleptic malignant syndrome

17 July 2024

1 reference

https://api.crossref.org/works/10.1080/13554791003623326

Partial Kluver-Bucy syndrome: two cases.

17 July 2024

1 reference

https://api.crossref.org/works/10.1080/13554791003623326

The Journal of Clinical Psychiatry

17 July 2024

Dhib-Jalbut S.

1987

1 reference

https://api.crossref.org/works/10.1080/13554791003623326

Treatment of catatonia with intravenous biperidene

17 July 2024

1 reference

https://api.crossref.org/works/10.1080/13554791003623326

Chromosome 3 linked frontotemporal dementia (FTD-3).

17 July 2024

1 reference

https://api.crossref.org/works/10.1080/13554791003623326

Bromocriptine treatment for perseveration in demented patients.

17 July 2024

1 reference

https://api.crossref.org/works/10.1080/13554791003623326

SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders

17 July 2024

1 reference

https://api.crossref.org/works/10.1080/13554791003623326

Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations

17 July 2024

1 reference

https://api.crossref.org/works/10.1080/13554791003623326

Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy

17 July 2024

1 reference

https://api.crossref.org/works/10.1080/13554791003623326

The Journal of Clinical Psychiatry

17 July 2024

357

Rosebush P. I.

1990

1 reference

https://api.crossref.org/works/10.1080/13554791003623326

Striatal and extra-striatal D(2)/D(3) dopamine receptor occupancy by quetiapine in vivo. [(123)I]-epidepride single photon emission tomography(SPET) study

17 July 2024

1 reference

https://api.crossref.org/works/10.1080/13554791003623326

Effects of recent and reference antipsychotic agents at human dopamine D2 and D3 receptor signaling in Chinese hamster ovary cells

17 July 2024

1 reference

https://api.crossref.org/works/10.1080/13554791003623326

Neurologia i Neurochirurgia Polska

17 July 2024

173

Wszolek Z. K.

2003

1 reference

https://api.crossref.org/works/10.1080/13554791003623326

17 July 2024

Identifiers

1 reference

15 September 2017

1 reference